Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig A Elmets

Showing results (141-150 of 172) with videos related to

Pageof 18
Sort By:
Journal of Dermatological Science|March 31, 2018
The retinoid X receptor agonist, 9-cis UAB30, inhibits cutaneous T-cell lymphoma proliferation through the SKP2-p27kip1 axisChu-Fang Chou, Yu-Hua Hsieh, Clinton J Grubbs, et al.
Oncotarget|September 29, 2015
Shh and p50/Bcl3 signaling crosstalk drives pathogenesis of BCCs in Gorlin syndromeSandeep C Chaudhary, Xiuwei Tang, Aadithya Arumugam, et al.
Journal of the American Academy of Dermatology|April 22, 2008
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologicsAlice Gottlieb, Neil J Korman, Kenneth B Gordon, et al.
Journal of the American Academy of Dermatology|April 22, 2008
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologicsAlan Menter, Alice Gottlieb, Steven R Feldman, et al.
Skin Pharmacology and Physiology|January 27, 2015
Prodifferentiation, anti-inflammatory and antiproliferative effects of delphinidin, a dietary anthocyanidin, in a full-thickness three-dimensional reconstituted human skin model of psoriasisJean Christopher Chamcheu, Harish C Pal, Imtiaz A Siddiqui, et al.
Inflammation|March 18, 2022
Ex Vivo Culture Models of Hidradenitis Suppurativa for Defining Molecular Pathogenesis and Treatment Efficacy of Novel DrugsKayla F Goliwas, Mahendra P Kashyap, Jasim Khan, et al.
Journal of the National Cancer Institute|December 1, 2010
Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trialCraig A Elmets, Jaye L Viner, Alice P Pentland, et al.
Journal of the American Academy of Dermatology|October 9, 2009
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapyAlan Menter, Neil J Korman, Craig A Elmets, et al.
Journal of the American Academy of Dermatology|February 17, 2009
Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapiesAlan Menter, Neil J Korman, Craig A Elmets, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2024
CD2 expressing innate lymphoid and T cells are critical effectors of immunopathogenesis in hidradenitis suppurativaMahendra Pratap Kashyap, Bharat Mishra, Rajesh Sinha, et al.
Pageof 18

Showing results (141-150 of 172) with videos related to

Sort By:
Pageof 18
Journal of Dermatological Science|March 31, 2018
The retinoid X receptor agonist, 9-cis UAB30, inhibits cutaneous T-cell lymphoma proliferation through the SKP2-p27kip1 axisChu-Fang Chou, Yu-Hua Hsieh, Clinton J Grubbs, et al.
Oncotarget|September 29, 2015
Shh and p50/Bcl3 signaling crosstalk drives pathogenesis of BCCs in Gorlin syndromeSandeep C Chaudhary, Xiuwei Tang, Aadithya Arumugam, et al.
Journal of the American Academy of Dermatology|April 22, 2008
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologicsAlice Gottlieb, Neil J Korman, Kenneth B Gordon, et al.
Journal of the American Academy of Dermatology|April 22, 2008
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologicsAlan Menter, Alice Gottlieb, Steven R Feldman, et al.
Skin Pharmacology and Physiology|January 27, 2015
Prodifferentiation, anti-inflammatory and antiproliferative effects of delphinidin, a dietary anthocyanidin, in a full-thickness three-dimensional reconstituted human skin model of psoriasisJean Christopher Chamcheu, Harish C Pal, Imtiaz A Siddiqui, et al.
Inflammation|March 18, 2022
Ex Vivo Culture Models of Hidradenitis Suppurativa for Defining Molecular Pathogenesis and Treatment Efficacy of Novel DrugsKayla F Goliwas, Mahendra P Kashyap, Jasim Khan, et al.
Journal of the National Cancer Institute|December 1, 2010
Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trialCraig A Elmets, Jaye L Viner, Alice P Pentland, et al.
Journal of the American Academy of Dermatology|October 9, 2009
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapyAlan Menter, Neil J Korman, Craig A Elmets, et al.
Journal of the American Academy of Dermatology|February 17, 2009
Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapiesAlan Menter, Neil J Korman, Craig A Elmets, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2024
CD2 expressing innate lymphoid and T cells are critical effectors of immunopathogenesis in hidradenitis suppurativaMahendra Pratap Kashyap, Bharat Mishra, Rajesh Sinha, et al.
Pageof 18